TNDM

Tandem Diabetes Care Inc

TNDM, USA

Tandem Diabetes Care, Inc. designs, develops, and commercializes technology solutions for people living with diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system; and Tandem Mobi insulin pump, an automated insulin delivery system. It also sells single-use products, including cartridges for storing and delivering insulin, and infusion sets that connect the insulin pump to the user's body. In addition, the company offers Tandem Device Updater used to update the pump software from a personal computer; Tandem Source, a web-based data management platform, which provides a visual way to display diabetes therapy management data from the pumps, integrated CGMs; and Sugarmate, a mobile app used to help people visualize diabetes therapy data. It has collaboration agreement with the University of Virginia Center for Diabetes Technology for research and development of fully automated closed-loop insulin delivery systems. The company was formerly known as Phluid Inc. and changed its name to Tandem Diabetes Care, Inc. in January 2008. Tandem Diabetes Care, Inc. was incorporated in 2006 and is headquartered in San Diego, California.

https://www.tandemdiabetes.com

Stock Price

$ 0.00

0% increase compared to yesterday.

Dividend

Frequency:

N/A

Rate:

N/A

Next Payout:

N/A
TNDM
stock
TNDM

Tandem Diabetes Care (TNDM): Reassessing Valuation After Fresh Concerns on Pump Demand and Negative EBITDA simplywall.st

Read more →
TNDM
stock
TNDM

Tandem Diabetes Care (TNDM) Sees Target Price Raised by Citigrou GuruFocus

Read more →

Showing 2 of 10

Analyst Ratings & Sentiment

(Last Updated 2025-09-30)

Rating:

BUY

Target Price:

$22.5238

Analyst Picks

Strong Buy

6

Buy

4

Hold

10

Sell

1

Strong Sell

0

Sentiment:

Bullish

Finn Analysis

(Last Updated 2025-09-30)

Health Score

Price to Book Ratio (P/B)

-

Very High

10.88

Low ≤ 1

High ≥ 3

Return on Equity (ROE)

-

Very Low

-15.92 %

Low ≤ 5%

High ≥ 25%

Return on Assets (ROA)

-

Very Low

-2.42 %

Low ≤ 2%

High ≥ 10%

Free Cash Flow - Revenue % (FCF)

-

Very Low

1.67 %

Low ≤ 5%

High ≥ 15%

Debt to Equity

-

Very Low

5.58

Low ≥ 1

High ≤ 0.3

Investors

* Institutions hold a combined 113.14% of the total shares of Tandem Diabetes Care Inc

1.

BlackRock Inc

(16.0895%)

since

2025/06/30

2.

Vanguard Group Inc

(10.907%)

since

2025/06/30

3.

Sessa Capital IM LP

(7.3998%)

since

2025/06/30

4.

iShares Core S&P Small-Cap ETF

(5.8693%)

since

2025/08/31

5.

GW&K Investment Management, LLC

(4.2773%)

since

2025/06/30

7.

State Street Corp

(3.9158%)

since

2025/06/30

8.

Hood River Capital Management LLC

(3.7961%)

since

2025/06/30

9.

Vanguard Total Stock Mkt Idx Inv

(3.1123%)

since

2025/07/31

10.

Vanguard Explorer Inv

(3.1032%)

since

2025/06/30

11.

Goldman Sachs Group Inc

(2.7919%)

since

2025/06/30

12.

Paradice Investment Management LLC

(2.6154%)

since

2025/06/30

13.

Stephens Inv Mgmt Group LLC

(2.5718%)

since

2025/06/30

14.

Jennison Associates LLC

(2.4552%)

since

2025/06/30

15.

Vanguard Small Cap Index

(2.3915%)

since

2025/07/31

16.

iShares Russell 2000 ETF

(2.3889%)

since

2025/08/31

17.

Geode Capital Management, LLC

(2.3773%)

since

2025/06/30

18.

Hood River Small-Cap Growth Instl

(2.1895%)

since

2025/06/30

19.

Ophir Asset Management Pty Ltd

(2.1681%)

since

2025/06/30

20.

Champlain Investment Partners, LLC

(2.1535%)

since

2025/06/30

21.

Jacobs Levy Equity Management, Inc.

(2.1183%)

since

2025/06/30

22.

UBS Group AG

(2.0482%)

since

2025/06/30

23.

Morgan Stanley - Brokerage Accounts

(1.8729%)

since

2025/06/30

24.

Two Sigma Investments LLC

(1.8244%)

since

2025/06/30

25.

Baillie Gifford & Co Limited.

(1.666%)

since

2025/06/30

26.

Stephens SMID Select Growth

(1.6438%)

since

2025/06/30

27.

Paradice Global Small Mid Cap Strategy

(1.6203%)

since

2025/03/31

28.

Brown Advisory Holdings Inc

(1.5645%)

since

2025/06/30

29.

Vanguard Small Cap Growth Index Inv

(1.3546%)

since

2025/07/31

30.

Bellevue Healthcare Ord

(1.1528%)

since

2024/11/30

31.

American Funds SMALLCAP World A

(1.1351%)

since

2025/06/30

32.

PGIM Jennison Health Sciences Z

(1.0838%)

since

2025/07/31

33.

Jennison Health Sciences Equity

(1.0838%)

since

2025/06/30

34.

Vanguard Institutional Extnd Mkt Idx Tr

(1.0614%)

since

2025/07/31

35.

Fidelity Small Cap Index

(0.993%)

since

2025/06/30

36.

GW&K Small/Mid Cap Core CIT I

(0.9473%)

since

2025/06/30

38.

iShares Russell 2000 Growth ETF

(0.8727%)

since

2025/08/31

39.

iShares S&P Small-Cap 600 Growth ETF

(0.8467%)

since

2025/08/31

40.

FIAM Small Cap Core Composite

(0.8052%)

since

2025/03/31

* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.

Earnings History

EPS ActualEPS EstimateEPS DifferenceSurprise Percent

Upcoming Earnings Release

Date

2025-12-31

EPS Estimate

-0.0863

Latest Release

Date

2025-09-30

EPS Actual

-0.31

EPS Estimate

-0.32

EPS Difference

0.01

Surprise Percent

3.125%

Investing Fit Scorecard

(Last Updated 2025-09-30)

Deep Value
Potential Value Candidate(3.5)
Defensive
Moderately Defensive(5.5)
Dividend
Weak Dividend Profile(3)
Economic Moat
Some Competitive Advantage(5.3)
GARP
Not Attractive for GARP(2.5)
Growth
Weak Growth Prospect(2.5)
Momentum
No Momentum(3)
Net Net
Not Undervalued (Net-Net)(2.5)
Quality
Low Quality Business(3)
Value
Overpriced(2)

Income Statement

(Last Updated 2025-09-30)

Revenue

$ 0

Cost Of Revenue

$ 0

Gross Profit

$ 0

Operating Expenses

$ 0

Operating Income

$ 0

Interest Expense

$ 0

Pretax Income

$ 0

Net Income

$ 0

Income Tax Expense

$ 0

EBITDA

$ 0

Total Other Income Expense Net

$ 0

Earnings Per Share

0

Dividends Per Share

0

Shares Outstanding

0

Operating Margin

0%

Trend

Balance Sheet

(Last Updated 2025-09-30)

Cash

$ 0

Short Term Investments

$ 0

Receivables

$ 0

Inventories

$ 0

Total Current Assets

$ 0

Property Plant Equipment

$ 0

Total Assets

$ 0

Payables

$ 0

Short Term Debt

$ 0

Long Term Debt

$ 0

Total Liabilities

$ 0

Equity

$ 0

Trend

Cash Flow

(Last Updated 2025-09-30)

Net Income

$ 0

Depreciation

$ 0

Change In Working Capital

$ 0

Cash From Operations

$ 0

Capital Expenditures

$ 0

Cash From Investing

$ 0

Cash From Financing

$ 0

Net Change In Cash

$ 0

Trend

Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.